PI3K/Akt/mTOR signaling pathway: a critical signal transduction pathway in the anti-cancer effects of resveratrol
Open Access
Abstract
No abstract availableFunding Information
- Tabriz University of Medical Sciences (72262)
This publication has 145 references indexed in Scilit:
- New strategies in ovarian cancer treatmentCancer, 2019
- Resveratrol: a review of plant sources, synthesis, stability, modification and food applicationJournal of the Science of Food and Agriculture, 2019
- Ovarian cancer: Current status and strategies for improving therapeutic outcomesCancer Medicine, 2019
- Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathwayIUBMB Life, 2018
- The Diagnosis and Treatment of Prostate CancerJAMA, 2017
- Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid TumorsJAMA Oncology, 2016
- Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathwayMolecular Carcinogenesis, 2015
- The Combination of Rapamycin and Resveratrol Blocks Autophagy and Induces Apoptosis in Breast Cancer CellsJournal of Cellular Biochemistry, 2014
- Cancer‐specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cellsMolecular Carcinogenesis, 2014
- Resveratrol modulates the phosphoinositide 3‐kinase pathway through an estrogen receptor α‐dependent mechanism: Relevance in cell proliferationInternational Journal of Cancer, 2003